Kendra Gregg serves as the Senior Director of Technical Services at Viatris, where she leverages her extensive expertise in the pharmaceuticals industry to drive innovation in oral solid dose formulations. With a robust background in Analytical Chemistry and a strong commitment to Good Laboratory Practice...
Kendra Gregg serves as the Senior Director of Technical Services at Viatris, where she leverages her extensive expertise in the pharmaceuticals industry to drive innovation in oral solid dose formulations. With a robust background in Analytical Chemistry and a strong commitment to Good Laboratory Practice (GLP) and regulatory compliance, Kendra plays a pivotal role in overseeing the scientific and technical aspects of process development and product launches. Her leadership is instrumental in executing cost reduction initiatives and managing technical investigations, ensuring that Viatris consistently delivers high-quality drug delivery systems that meet stringent U.S. Food and Drug Administration (FDA) standards.
In her current role, Kendra is at the forefront of several key projects that focus on the optimization of manufacturing processes and the successful transfer of technology across global teams. Her strategic approach to product transfers not only enhances operational efficiency but also fosters collaboration among cross-functional teams, aligning scientific advancements with sound business practices. Kendra's adeptness in navigating the complexities of regulatory affairs and her commitment to continuous process improvement have made her a respected figure in the industry.
Kendra's educational foundation, with a Bachelor of Arts in Chemistry, complements her professional journey, equipping her with the analytical skills necessary to tackle the challenges of modern pharmaceutical development. As a member of the global management team, she is dedicated to driving the future of oral solid dose technologies, ensuring that Viatris remains a leader in delivering innovative healthcare solutions. Her passion for advancing science and technology is evident in her work, making her a vital asset to both her team and the broader pharmaceutical community.
